NewAmsterdam Pharma Company N.V.

NAMS · NASDAQ

NewAmsterdam Pharma Company N.V.NAMS · NASDAQ

Regular Market · Oct 30, 08:00 PM

$20.06-$0.70 -3.38%

After Hours $20.05 -$0.01 -0.04%

Oct 30, 08:20 PM

High: —
Low: —
Volume: —

Loading chart…

Ask Alva about NAMS

NewAmsterdam Pharma Company N.V.

NAMS · Biotechnology

20.06 USD

-0.70 (-3.38%)

At Close

20.05 USD

-0.01 (-0.04%)

After hours

High
Low
Volume
Open
Prev Close
Turnover
Trailing P/E
Market Cap
Turnover Ratio
Free Float
Post-Market
VWAP
Range (%)
Volume Ratio
52-Wk High
52-Wk Low
Forward P/E
Beta

NewAmsterdam Pharma Company N.V.

NAMS · NASDAQ

At Close

20.06 USD

-0.70 (-3.38%)

After hours 20.05 USD -0.01 (-0.04%)

High
Low
Volume
Open
Prev Close
Turnover
Trailing P/E
Market Cap
Turnover Ratio
Free Float
Post-Market
VWAP
Range (%)
Volume Ratio
52-Wk High
52-Wk Low
Forward P/E
Beta

Unusual Price Movement

NAMS continued to fall sharply despite a broad risk-off session and rising biotech peers.

No new catalyst: NAMS was down about 4.5%, extending the earlier selloff amid a sharp U.S. risk-off session. The S&P 500 and Nasdaq fell while volatility jumped, but XLV, Amgen, and Regeneron rose, leaving the decline driven primarily by continuing NAMS-specific selling.

Unusual Price Movement

NAMS continued to fall sharply despite a broad risk-off session and rising biotech peers.

Ask Alva anything. @ for context, / for skills

Ask Alva about NAMS

NAMS continued to fall sharply despite a broad risk-off session and rising biotech peers. ⓘ

NAMS continued to fall sharply despite a broad risk-off session and rising biotech peers. ⓘ

NAMS continued to fall sharply despite a broad risk-off session and rising biotech peers.

NAMS continued to fall sharply despite a broad risk-off session and rising biotech peers.